Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in About Cookies.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. (DSM‐IV). 4th Edition. Washington, DC: American Psychiatric Association, 1994.
Botts 1999
Botts SR, Raskind J. Gabapentin and tiagabine in bipolar disorder. American Journal of Health System Pharmacy 1999;56(19):1939‐44.
Calabrese JR, Bowden CL, Sachs GS, Ascher JA, Monaghan E, Rudd GD. A double‐blind placebo controlled study of lamotigine montherapy in out‐patients with bipolar 1 depression. Journal of Clinical Psychiatry 1999;60(2):79‐88.
Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, et al. A double‐blind placebo‐controlled prophylaxis study of lamotrogine in rapid‐cycling bipolar disorder. Journal of Clinical Psychiatry 2000;61(11):841‐50.
Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, et al. A placebo‐controlled evaluation of tiagabine and gabapentin monotherapy in refractory mood disorders. Journal of Clinical Psychopharmacology 2000;20(6):607‐14.
Grunze H, Erfurth A, Marcuse A, Amann B, Normann C, Walden J. Tiagabine appears not to be efficacious in the treatment of acute mania. Journal of Clinical Psychiatry 1999;60(11):759‐62.
Ichim L, Berk M, Brook S. Tiagabine compare with lithium in mania: a double‐blind, randomised controlled trial. Annals of Clinical Psychiatry 2000;12(1):5‐20.
Kalviainen R, Noursiainenen I, Mantyjarvi M, et al. Absence of concentric visual field defects in patients with long term tiagabine monotherapy. Neurology 1999;52(Suppl 2):236.
Keck PE, McElroy SL, Strakowski SM, Soutullo CA. Antipsychotics in the treatment of mood disorders and risk of tardive dyskinesia. Journal of Clinical Psychiatry 2000;61(Suppl 4):33‐8.
Leach MJ, Marsden CM, Miller AA. Pharmacological studies on tiagabine, a novel potential antiepileptic drug: ii. Neurochemical studies on the mechanism of action. Epilepsia 1986;27(5):490‐7.
Schaffer LC, Schaffer CB. An open case series on the utility of tiagabine as an augmentation in refractory bipolar outpatients. Journal of Affective Disorders 2002;71(1‐3):259‐63.
Suzdak PD, Jansen JA. A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor. Epilepsia 1995;36(6):612‐26.
World Health Organisation. The ICD‐10 Classification of mental and behavioural disorders. Clinical descriptions and diagnostic guidelines. Geneva: World Health Organisation, 1992..
All sections are selected by default, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.
Select/deselect all
The data available are protected by copyright and may only be used in accordance with the Terms and Conditions.